M. Lind
Impact in
- Hematology top 10%
- Erythropoietin and Anemia Treatment
- Hematopoietic Stem Cell Transplantation
- Iron Metabolism and Disorders
- Oncology top 10%
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
- Co-authors
- P M Wilkinson (3 shared papers)Helen Doll (1 shared paper)C. C. Vernon (1 shared paper)Tim Littlewood (1 shared paper)D Wild (1 shared paper)Crispin Jenkinson (1 shared paper)N Stuart (1 shared paper)Deborah Cruickshank (1 shared paper)
- Journals
- Annals of Oncology (4 papers)British Journal of Cancer (3 papers)Frontiers in Immunology (2 papers)European Journal of Cancer (2 papers)Journal of Rehabilitation Medicine (1 paper)
- Partner nations
- United KingdomGermanyAustralia
In The Last Decade
M. Lind
19 papers receiving 475 citations
Peers
Comparison fields: 5 of 77
- Hematology 143
- Oncology 241
- Genetics 68
- Reproductive Medicine 53
- Cancer Research 70
Countries citing papers authored by M. Lind
This map shows the geographic impact of M. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lind more than expected).
Fields of papers citing papers by M. Lind
This network shows the impact of papers produced by M. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lind. The network helps show where M. Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 91 | |
| 2 | 1999 | 49 | |
| 3 | 2003 | 44 | |
| 4 | 2004 | 39 | |
| 5 | 2006 | 39 | |
| 6 | 2014 | 31 | |
| 7 | 1998 | 31 | |
| 8 | Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion. | 1995 | 30 |
| 9 | 1993 | 25 | |
| 10 | 2011 | 23 | |
| 11 | 1996 | 23 | |
| 12 | 1999 | 18 | |
| 13 | Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. | 1999 | 13 |
| 14 | Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study. | 1996 | 12 |
| 15 | 1993 | 11 | |
| 16 | 2000 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 1997 | 1 | |
| 19 | 1995 | 1 | |
| 20 | 2025 | 0 |
About M. Lind
M. Lind is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Molecular Biology and Cancer Research, having authored 21 papers that have together received 484 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Erythropoietin and Anemia Treatment (2 papers), Lung Cancer Research Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (143 citations), Oncology (241 citations), Genetics (68 citations), Reproductive Medicine (53 citations) and Cancer Research (70 citations). M. Lind has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include P M Wilkinson, Helen Doll, C. C. Vernon, Tim Littlewood, D Wild, Crispin Jenkinson, N Stuart, Deborah Cruickshank, P. Kosmidis and Donald M. Hadley. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Frontiers in Immunology, European Journal of Cancer and Journal of Rehabilitation Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.